Ghosh S - Search Results

1

Chronic exposure to Helicobacter pylori impairs dendritic cell function and inhibits Th1 development.

Mitchell P, Germain C, Fiori PL, Khamri W, Foster GR, Ghosh S, Lechler RI, Bamford KB, Lombardi G. Mitchell P, et al. Among authors: ghosh s. Infect Immun. 2007 Feb;75(2):810-9. doi: 10.1128/IAI.00228-06. Epub 2006 Nov 13. Infect Immun. 2007. PMID: 17101659 Free PMC article.

2

Modulation of dendritic cell phenotype and function in an in vitro model of the intestinal epithelium.

Butler M, Ng CY, van Heel DA, Lombardi G, Lechler R, Playford RJ, Ghosh S. Butler M, et al. Among authors: ghosh s. Eur J Immunol. 2006 Apr;36(4):864-74. doi: 10.1002/eji.200535497. Eur J Immunol. 2006. PMID: 16544275 Free article.

3

Coeliac disease and the risk of infections.

Walters JR, Bamford KB, Ghosh S. Walters JR, et al. Among authors: ghosh s. Gut. 2008 Aug;57(8):1034-5. doi: 10.1136/gut.2008.151571. Epub 2008 Apr 9. Gut. 2008. PMID: 18400879 No abstract available.

4

Comparison of cytokine modulation by natural peroxisome proliferator-activated receptor gamma ligands with synthetic ligands in intestinal-like Caco-2 cells and human dendritic cells--potential for dietary modulation of peroxisome proliferator-activated receptor gamma in intestinal inflammation.

Marion-Letellier R, Butler M, Déchelotte P, Playford RJ, Ghosh S. Marion-Letellier R, et al. Among authors: ghosh s. Am J Clin Nutr. 2008 Apr;87(4):939-48. doi: 10.1093/ajcn/87.4.939. Am J Clin Nutr. 2008. PMID: 18400717 Free article.

5

NOD2 activity modulates the phenotype of LPS-stimulated dendritic cells to promote the development of T-helper type 2-like lymphocytes - Possible implications for NOD2-associated Crohn's disease.

Butler M, Chaudhary R, van Heel DA, Playford RJ, Ghosh S. Butler M, et al. Among authors: ghosh s. J Crohns Colitis. 2007 Dec;1(2):106-15. doi: 10.1016/j.crohns.2007.08.006. Epub 2007 Sep 27. J Crohns Colitis. 2007. PMID: 21172192

6

Beyond TNF, Th1 and Th2 in inflammatory bowel disease.

Shale M, Ghosh S. Shale M, et al. Among authors: ghosh s. Gut. 2008 Oct;57(10):1349-51. doi: 10.1136/gut.2008.151563. Gut. 2008. PMID: 18791115 No abstract available.

7

Synergistic enhancement of Toll-like receptor responses by NOD1 activation.

van Heel DA, Ghosh S, Butler M, Hunt K, Foxwell BM, Mengin-Lecreulx D, Playford RJ. van Heel DA, et al. Among authors: ghosh s. Eur J Immunol. 2005 Aug;35(8):2471-6. doi: 10.1002/eji.200526296. Eur J Immunol. 2005. PMID: 16021603 Free article.

8

Normal responses to specific NOD1-activating peptidoglycan agonists in the presence of the NOD2 frameshift and other mutations in Crohn's disease.

van Heel DA, Hunt KA, Ghosh S, Hervé M, Playford RJ. van Heel DA, et al. Among authors: ghosh s. Eur J Immunol. 2006 Jun;36(6):1629-35. doi: 10.1002/eji.200535636. Eur J Immunol. 2006. PMID: 16637007 Free article.

9

Novel treatment options for inflammatory bowel disease: targeting alpha 4 integrin.

Lanzarotto F, Carpani M, Chaudhary R, Ghosh S. Lanzarotto F, et al. Among authors: ghosh s. Drugs. 2006;66(9):1179-89. doi: 10.2165/00003495-200666090-00002. Drugs. 2006. PMID: 16827596 Review.

10

Learning the lessons of antitumour necrosis factor therapy-associated psoriasis.

Shale M, Ghosh S. Shale M, et al. Among authors: ghosh s. Can J Gastroenterol. 2009 Oct;23(10):674-6. doi: 10.1155/2009/514618. Can J Gastroenterol. 2009. PMID: 19826641 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,926 results

Search Page

Filters